期刊文献+

ADO在膀胱尿路上皮癌组织中的表达和意义

Expression and clinical significance of ADO in bladder urothelial cancer
下载PDF
导出
摘要 目的探讨膀胱尿路上皮癌组织中腺苷(adenosine,ADO)的表达及临床意义。方法收集武汉大学人民医院病理科2000-2006年有完整临床和病理资料的膀胱尿路上皮癌存档蜡块50例和5例癌旁组织,采用免疫组织化学S-P法检测50例膀胱尿路上皮癌和5例癌旁组织中ADO的表达水平。采用HPIAS-1000高清晰度彩色病理图文报告管理系统,对ADO的表达进行定量分析,并用SPSS13.0软件对各组免疫组织化学反应阳性颗粒的平均光密度、阳性面积率做单因素方差分析和SNK(q)检验。结果 ADO在膀胱尿路上皮癌中呈低表达,癌旁组织中呈高表达。膀胱尿路上皮癌与癌旁组织相比,差异有显著性(P<0.05)。结论 ADO在膀胱尿路上皮癌中的低表达抑制了肿瘤细胞的凋亡,导致肿瘤细胞增生,ADO在膀胱尿路上皮癌的发生、发展中起了重要的促进作用。 Objective To investigate the expression and clinical significance of ADO in bladder urothelial cancer.Methods Parafflin-embeded specimen from 50 cases of bladder urothelial cancer and 5 cases of normal tissues near the bladder urothelial cancer,which were all filed with full pathological and clinical data,were collected from the pathology department of the Renmin Hospital of Wuhan University between 2000 and 2006.The expression of ADO was detected by immunohistochemical S-P method.Quantitative analysis of ADO was conducted by high definition pathological graphics context report system (HPIAS-1000).One-way analysis of variance and SNK(q) tests were used to analyse the mean density and the positive area rate of the immunohistochemical results.Results The expression of ADO in bladder urothelial cancer was lower than that in normal tissues(P0.05).Conclusion The low expression of ADO in bladder urothelial cancer suppresses the apoptosis of tumour cells and causes tumour cell proliferation,so ADO plays an important role in the occurrence and the development of bladder urothelial cancer.
作者 陕光 唐甜
出处 《中国组织化学与细胞化学杂志》 CAS CSCD 2011年第3期267-270,共4页 Chinese Journal of Histochemistry and Cytochemistry
关键词 膀胱尿路上皮癌 ADO 免疫组织化学 Bladder urothelial cancer ADO Immunohistochemistry
  • 相关文献

参考文献1

二级参考文献55

  • 1[22]Lee HT,Gallos G,Nasr SH,Emala CW.A1 adenosine receptor activation inhibits inflammation,necrosis,and apoptosis after renal ischemia-reperfusion injury in mice.J Am Soc Nephrol 2004; 15:102-111
  • 2[23]Randhawa MP,Lasley RD,Mentzer RM Jr.Salutary effects of exogenous adenosine administration on in vivo myocardial stunning.J Thorac Cardiovasc Surg 1995; 110:63-74
  • 3[24]Sekili S,Jeroudi MO,Tang XL,Zughaib M,Sun JZ,Bolli R.Effect of adenosine on myocardial 'stunning' in the dog.Circ Res 1995; 76:82-94
  • 4[25]Yoshimura Y,Kristo G,Keith BJ,Jahania SA,Mentzer RM Jr,Lasley RD.The p38 MAPK inhibitor SB203580 blocks adenosine A(1) receptor-induced attenuation of in vivo myocardial stunning.Cardiovasc Drugs and Ther 2004; 18:433-440
  • 5[26]Sugino H,Shimada H,Tsuchimoto K.Role of adenosine in renal protection induced by a brief episode of ischemic preconditioning in rats.Jpn J Pharmacol 2001; 87:134-142
  • 6[27]Lee HT,Xu H,Nasr SH,Schnermann J,Emala CW.A1 adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion.Am J Physiol Renal Physiol 2004; 286:F298-F306
  • 7[28]Nakamura M,Nakakimura K,Matsumoto M,Sakabe T.Rapid tolerance to focal cerebral ischemia in rats is attenuated by adenosine A1 receptor antagonist.J Cereb Blood Flow Metab 2002; 22:161-170
  • 8[29]Hiraide T,Katsura K,Muramatsu H,Asano G,Katayama Y.Adenosine receptor antagonists cancelled the ischemic tolerance phenomenon in gerbil.Brain Res 2001; 910:94-98
  • 9[30]Kudo M,Wang Y,Xu M,Ayub A,Ashraf M.Adenosine A(1)receptor mediates late preconditioning via activation of PKCdelta signaling pathway.Am J Physiol Heart Circ Physiol 2002;283:H296-H301
  • 10[31]Zhao X,Alexander JS,Zhang S,Zhu Y,Sieber NJ,Aw TY,Carden DL.Redox regulation of endothelial barrier integrity.Am J Physiol Lung Cell Mol Physiol 2001; 281:L879-L886

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部